Status:
RECRUITING
Prospective Investigation of Intra-Articular Tranexamic Acid Use in Elective Hip Arthroplasty
Lead Sponsor:
St. Anne's University Hospital Brno, Czech Republic
Conditions:
Blood Loss
Hemoglobin Change
Eligibility:
All Genders
Brief Summary
Tranexamic acid (trans-4-aminomethyl cyclohexane carboxylic acid) is an antifibrinolytic substance that chemically belongs to the group of e-carboxylic acids. TXA is a synthetic amino acid derivative ...
Eligibility Criteria
Inclusion
- Elective hip replacement
Exclusion
- Traumatic hip replacement indication
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT06903299
Start Date
January 1 2023
End Date
December 31 2026
Last Update
April 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First Department of Orthopaedic Surgery, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czechia
Brno, Czechia, Czechia, 62700